RU2008122133A - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS - Google Patents
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS Download PDFInfo
- Publication number
- RU2008122133A RU2008122133A RU2008122133/15A RU2008122133A RU2008122133A RU 2008122133 A RU2008122133 A RU 2008122133A RU 2008122133/15 A RU2008122133/15 A RU 2008122133/15A RU 2008122133 A RU2008122133 A RU 2008122133A RU 2008122133 A RU2008122133 A RU 2008122133A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- antiseptic
- carbohydrate
- lactic acid
- component
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 7
- 208000015181 infectious disease Diseases 0.000 title claims abstract 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract 8
- 230000002421 anti-septic effect Effects 0.000 claims abstract 6
- 150000001720 carbohydrates Chemical class 0.000 claims abstract 6
- 235000014655 lactic acid Nutrition 0.000 claims abstract 6
- 239000004310 lactic acid Substances 0.000 claims abstract 6
- 210000001215 vagina Anatomy 0.000 claims abstract 5
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract 4
- 239000011668 ascorbic acid Substances 0.000 claims abstract 4
- 229960005070 ascorbic acid Drugs 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims abstract 4
- 235000010378 sodium ascorbate Nutrition 0.000 claims abstract 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims abstract 4
- 229960005055 sodium ascorbate Drugs 0.000 claims abstract 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims abstract 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract 2
- 229930006000 Sucrose Natural products 0.000 claims abstract 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract 2
- JQQZCIIDNVIQKO-UHFFFAOYSA-N benzyl-dimethyl-[3-(tetradecanoylamino)propyl]azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1 JQQZCIIDNVIQKO-UHFFFAOYSA-N 0.000 claims abstract 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract 2
- 229960003260 chlorhexidine Drugs 0.000 claims abstract 2
- 239000002552 dosage form Substances 0.000 claims abstract 2
- 229930182830 galactose Natural products 0.000 claims abstract 2
- 239000008103 glucose Substances 0.000 claims abstract 2
- 229960000448 lactic acid Drugs 0.000 claims abstract 2
- 239000008101 lactose Substances 0.000 claims abstract 2
- 229920000847 nonoxynol Polymers 0.000 claims abstract 2
- 239000007787 solid Substances 0.000 claims abstract 2
- 239000005720 sucrose Substances 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция для лечения урогенитальных инфекций в дозированной форме, содержащая антисептик - хлоргексидина биглюконат и основу - полиэтиленоксид, отличающаяся тем, что она дополнительно содержит компонент, обеспечивающий естественную кислотность влагалища и углевод, а в качестве антисептика она может также содержать ноноксинол или мирамистин, а в качестве основы - витепсол, или твердый жир при следующем соотношении компонентов, мас.%: ! Антисептикне более 0,67Компонент, обеспечивающий естественную кислотность влагалищане более 16,67Углеводне более 3,33Основадо 100 ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что в качестве компонента, обеспечивающего естественную кислотность влагалища, она содержит молочную кислоту, или аскорбиновую кислоту, или аскорбат натрия, или смесь молочной кислоты и аскорбиновой кислоты в соотношении 1:1, или смесь молочной кислоты и аскорбата натрия в соотношении 1:1. ! 3. Фармацевтическая композиция по п.1, отличающаяся тем, что в качестве углевода она содержит лактозу, или глюкозу, или сахарозу, или галактозу.1. A pharmaceutical composition for treating urogenital infections in a dosage form containing an antiseptic - chlorhexidine bigluconate and a base - polyethylene oxide, characterized in that it additionally contains a component that provides the natural acidity of the vagina and carbohydrate, and as an antiseptic, it can also contain nonoxynol or miramistin, and as a basis - vitepsol, or solid fat in the following ratio of components, wt.%:! Antiseptic more than 0.67 A component that provides the natural acidity of the vagina more than 16.67 Carbohydrate more than 3.33 Basically 100! 2. The pharmaceutical composition according to claim 1, characterized in that as a component that provides the natural acidity of the vagina, it contains lactic acid, or ascorbic acid, or sodium ascorbate, or a mixture of lactic acid and ascorbic acid in a ratio of 1: 1, or a mixture lactic acid and sodium ascorbate in a ratio of 1: 1. ! 3. The pharmaceutical composition according to claim 1, characterized in that it contains lactose, or glucose, or sucrose, or galactose, as a carbohydrate.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008122133/15A RU2008122133A (en) | 2008-06-02 | 2008-06-02 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008122133/15A RU2008122133A (en) | 2008-06-02 | 2008-06-02 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008122133A true RU2008122133A (en) | 2009-12-10 |
Family
ID=41489077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008122133/15A RU2008122133A (en) | 2008-06-02 | 2008-06-02 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2008122133A (en) |
-
2008
- 2008-06-02 RU RU2008122133/15A patent/RU2008122133A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2895187T1 (en) | Daptomycin formulations and applications thereof | |
| RU2008122133A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS | |
| RU2008109778A (en) | OINTMENT FOR TREATMENT OF THERMAL BURNS, METHOD FOR ITS PREPARATION AND METHOD FOR TREATMENT | |
| RU2010129409A (en) | METHOD FOR TREATING RABBIT PSOROPTOSIS AND CARNIVOR ANIMAL OTODEKTOSIS | |
| RU2008122166A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS | |
| RU2007149566A (en) | METHOD FOR OBTAINING COMPLEX IMMUNITY OF A MULTI-DRUG FOR IMPROVING NATURAL RESISTANCE OF ANIMAL ORGANISM | |
| RU2012145882A (en) | COMPOSITION FOR STIMULATION OF ENERGY-METABOLIC PROCESSES AND METHOD FOR PREVENTION OF THE GENERAL PATHOLOGIES AND POST-PERMANENT DISEASES IN COWS | |
| CN108671058A (en) | Clean bacteriostasis spray of woman and its preparation method and application | |
| RU2008137463A (en) | DRUG FOR TREATMENT AND PREVENTION OF DISORDERS OF SELENIUM EXCHANGE FOR AGRICULTURAL ANIMALS | |
| RU2009114033A (en) | MEANS AND METHOD FOR TREATING ENDOMETRITIS IN COWS | |
| KR102086160B1 (en) | Natural preservative composition and wet tissue | |
| CN110885716A (en) | Antibacterial detergent | |
| KR20200119149A (en) | Effervescent feminine cleanser with various functions | |
| RU2007147513A (en) | EXTERNAL MEANS FOR TREATMENT OF DISEASES OF JOINTS AND SOFT TISSUES | |
| RU2008105588A (en) | Composition for the treatment of purulent wounds and trophic ulcers | |
| Zazgornik et al. | Citric acid inhibits growth of Helicobacter pylori in vitro: a new strategy for eradication | |
| RU2007100327A (en) | METHOD FOR TREATING PURULENT WASTE IN ANIMALS | |
| RU2013131611A (en) | MEANS FOR TREATMENT OF ENTERITIS IN ANIMALS | |
| RU2009107473A (en) | COMPOSITION FOR TREATING BURN WASES AND PREPARING THE RAS FOR AUTODERMOPLASTICS | |
| RU2008133255A (en) | DENTAL GEL BASED ON GLUCOSAMINE HYDROCHLORIDE FOR TREATMENT AND PREVENTION OF PERIODONTITIS | |
| RU2008123673A (en) | OINTMENT FOR TREATING BURN DISEASES WITH ALBUMIN AND PROPOLIS EXTRACT | |
| CN121265493A (en) | Compound containing mung bean hull n-butanol phase and preparation and application thereof | |
| RU2005114759A (en) | PHYTOMINERAL BIOSTIMULATING AGENT AND METHOD OF ITS APPLICATION | |
| RU2010126820A (en) | PREBIOTIC, STIMULATING VAGINAL LACTOFLORA GROWTH | |
| RU2008100977A (en) | "DIARON" PREPARATION FOR TREATMENT OF ACUTE GASTROINTESTINAL DISEASES OF NEWBORN CALVES |